Melanoma / Skin Cancer

Melanoma Care: Early Detection, Staging & Surgical Precision

 

Melanoma is the most serious form of skin cancer, developing in the pigment-producing cells known as melanocytes. While it accounts for a smaller percentage of skin cancer diagnoses compared to basal cell or squamous cell carcinomas, melanoma is significantly more aggressive due to its ability to spread rapidly to lymph nodes and internal organs if not caught early.

 

When detected in its localized, early stages, melanoma has a 5-year survival rate exceeding 99%. At Destination Dermatology, we combine rapid-access clinical screenings, digital dermoscopy, precise pathology evaluations, and definitive surgical care to catch and cure melanoma at the earliest possible phase.

The ABCDEs of Melanoma: What to Look For

Melanoma often develops in pre-existing moles or appears unexpectedly as a new, unusual spot on otherwise normal skin. Recognizing the warning signs early can save your life. We recommend evaluating your skin monthly using the ABCDE guide:

 

  • A – Asymmetry: One half of the mole or spot does not match the shape of the other half.
  • B – Border: The edges are irregular, ragged, notched, blurred, or poorly defined.
  • C – Color: The color is uneven, displaying shades of brown or black, or patches of pink, red, white, or blue.
  • D – Diameter: The spot is larger than 6 millimeters across (about the size of a pencil eraser), though melanomas can sometimes be smaller.
  • E – Evolving: The mole is changing in size, shape, color, or elevation over time, or developing new symptoms like itching, bleeding, or crusting.

 

The “Ugly Duckling” Sign: A mole that looks, feels, or grows differently from all the surrounding spots on your body should always be evaluated promptly by a board-certified dermatologist.

  • Diagnostic Excellence & Biopsy Protocol

    If a suspicious lesion is identified during a clinical examination, immediate and accurate pathology evaluation is essential. Our diagnostic workflow follows strict oncological guidelines:

     

    1. High-Magnification Dermoscopy: Non-invasive evaluation of pigment distribution, structural network patterns, and vascular structures using polarized light dermoscopy.
    2. Excisional or Biopsy Protocol: We perform a targeted biopsy—preferring full-thickness excisional biopsies whenever feasible—to ensure the dermatopathologist can evaluate the entire depth and architecture of the lesion.
    3. Histopathological Staging & Breslow Depth: Our specialized dermatopathology analysis measures the Breslow Depth (the exact thickness of the melanoma in millimeters from the skin’s surface). Breslow depth is the single most critical factor in determining the stage and appropriate surgical margins.
    4. Multidisciplinary Treatment Planning: For localized disease, definitive surgical care is planned immediately. For deeper or higher-risk lesions, we coordinate closely with surgical oncology specialists for sentinel lymph node evaluation.
     

Treatment Options for Melanoma

Surgical management remains the primary, definitive treatment for localized melanoma. The choice of treatment depends on the lesion’s stage, thickness, and anatomical location.

Procedure

Clinical Indication

Description

Goal

Wide Local Excision (WLE)

Primary, localized melanoma (In Situ through Stage II).

Surgical removal of the melanoma site along with a clinically calculated margin of healthy surrounding skin and subcutaneous tissue.

Complete local tumor eradication with clear histological margins.

Melanoma In Situ Excision

Stage 0 (confined strictly to the outer epidermis).

Precision excision with standardized 5mm safety margins to preserve tissue while ensuring complete clearance.

Curative removal before invasion into blood vessels or lymphatics occurs.

Sentinel Lymph Node Biopsy (SLNB) Coordination

Invasive melanomas (>0.8mm thick or with high-risk features).

Referral and coordination with surgical oncologists to evaluate the nearest lymph node basin before wide excision.

Accurate staging to rule out microscopic regional spread.

Digital Surveillance & Mapping

High-risk individuals with dysplastic nevus syndrome or prior melanoma.

Automated baseline imaging and total body photo-surveillance to detect secondary primary melanomas immediately.

Early interception of recurrent or new lesions.

    • Structured Surgical Care Steps

      Stage

      Milestones & Process

      1. Immediate Biopsy & Evaluation

      Fast-track tissue sampling under local anesthesia with expedited dermatopathology turnaround.

      2. Staging & Margin Determination

      Careful review of Breslow thickness, ulceration status, and mitotic rate to set precise surgical safety margins.

      3. Wide Local Surgical Excision

      Outpatient surgical removal under local anesthesia, ensuring full clearance of any microscopic peripheral disease.

      4. Advanced Reconstruction

      Meticulous wound closure utilizing plastic surgery principles to minimize scarring and restore natural contours.

      5. Long-Term Skin Surveillance

      Structured skin check schedule every 3 to 6 months for the first several years to guard against new or recurrent disease.

Frequently Asked Questions


What is the difference between Melanoma In Situ and Invasive Melanoma?


Melanoma In Situ (Stage 0) means the cancerous melanocytes are confined entirely to the top layer of skin (the epidermis) and have not grown into deeper layers. It carries zero risk of spreading to other parts of the body when completely excised. Invasive Melanoma has grown into the dermis layer below, where blood vessels and lymphatic channels exist, making proper staging and surgical clearance critical.


How wide are the surgical margins for a melanoma excision?


Surgical safety margins are determined by national guidelines based on the tumor’s Breslow depth. Margins typically range from 0.5 cm for Melanoma In Situ, 1 cm for thin melanomas (1mm or less), up to 2 cm for thicker melanomas.


Will I need chemotherapy or immunotherapy for melanoma?


For the majority of early-stage, localized melanomas (Stage 0, I, and II), wide local surgical excision is the only treatment needed. Advanced targeted therapies or immunotherapies are typically reserved for higher-stage melanomas that have spread to lymph nodes or distant organs.


How often do I need skin checks after a melanoma diagnosis?


Having a history of melanoma increases your risk of developing a second primary melanoma. We generally recommend full-body skin examinations every 3 to 6 months for the first two years, every 6 to 12 months for up to five years, and annually thereafter for life.


Schedule a Comprehensive Melanoma Screening


Early detection is your most powerful tool against melanoma. If you have a mole that is changing, bleeding, itching, or looks different from the rest, contact Destination Dermatology right away.